Pharmacokinetics of recombinant human insulin-like growth factor-1 in dialysis patients

This publication has 21 references indexed in Scilit:

• Efficacy and safety of growth hormone treatment in short children with renal allografts: Three year experience
  Kidney International, 1993
• Treatment of Insulin-Resistant Diabetic Ketoacidosis with Insulin-like Growth Factor I in an Adolescent with Insulin-Dependent Diabetes
  New England Journal of Medicine, 1992
• Effects of insulin-like growth factor on linear growth, head circumference, and body fat in patients with Laron-type dwarfism
  The Lancet, 1992
• Pharmacokinetic Profile of Recombinant Human Insulin‐Like Growth Factor I Given Subcutaneously in Normal Subjects
  Acta Paediatrica, 1991
• Recombinant human growth hormone treatment of children with chronic renal failure: long-term (1- to 3-year) outcome
  Pediatric Nephrology, 1991
• Short-Term Metabolic Effects of Recombinant Human Insulin-like Growth Factor I in Healthy Adults
  New England Journal of Medicine, 1987
• New standards of weight and body composition by frame size and height for assessment of nutritional status of adults and the elderly
  The American Journal of Clinical Nutrition, 1984
• Preferential Measurement of Insulin-Like Growth Factor (IGF) I-Related Peptides in Serum with the Aid of IGF-Binding Proteins (IGF BPs) Produced by Rat Liver in Culture. Estimation of Serum IGF BP Levels*
  Journal of Clinical Endocrinology & Metabolism, 1984
• Inhibition of Access of Bound Somatomedin to Membrane Receptor and Immunobinding Sites: A Comparison of Radioreceptor and Radioimmunoassay of Somatomedin in Native and Acid-Ethanol-Extracted Serum*
  Journal of Clinical Endocrinology & Metabolism, 1980
• A program package for simulation and parameter estimation in pharmacokinetic systems
  Computer Programs in Biomedicine, 1979